Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in OvaScience (NASDAQ: OVAS) in connection to alleged violations of securities laws by OVAS and certain of its officers. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in OvaScience’s Secondary Offering of 2.3…

Read More